Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Total Non-Current Liabilities (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Total Non-Current Liabilities for 13 consecutive years, with $689.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Non-Current Liabilities changed 0.22% year-over-year to $689.3 million, compared with a TTM value of $689.3 million through Sep 2025, changed 0.22%, and an annual FY2024 reading of $672.2 million, up 10.7% over the prior year.
  • Total Non-Current Liabilities was $689.3 million for Q3 2025 at Tandem Diabetes Care, roughly flat from $690.4 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $729.8 million in Q1 2025 and bottomed at $412.6 million in Q1 2021.
  • Average Total Non-Current Liabilities over 5 years is $595.8 million, with a median of $602.2 million recorded in 2022.
  • The sharpest move saw Total Non-Current Liabilities skyrocketed 272.17% in 2021, then decreased 0.15% in 2023.
  • Year by year, Total Non-Current Liabilities stood at $454.2 million in 2021, then rose by 29.67% to $588.9 million in 2022, then grew by 3.1% to $607.2 million in 2023, then rose by 10.7% to $672.2 million in 2024, then rose by 2.55% to $689.3 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for TNDM at $689.3 million in Q3 2025, $690.4 million in Q2 2025, and $729.8 million in Q1 2025.